Hematology
News
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.
Article
Cancer Data Trends 2022
News
First-line CAR T-cell therapy could help cure some lymphomas
Axi-cel is already approved for some forms of relapsed/refractory lymphoma, and a new phase 2 study hints that it has potential as a frontline...
News
Eating olive oil may slow CLL disease progression
A pilot study in Greece suggested that consuming extra virgin olive oil daily induced the apoptosis of cancer cells.
Article
Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera
Patients with polycythemia vera, a chronic myeloproliferative neoplasm, have a greater morbidity and mortality risk than the general population,...
Latest News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
Latest News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
News
Stopping venetoclax treatment early reduces CLL survival outcomes
Survival outcomes are decreased with early, permanent discontinuation of venetoclax but unchanged by treatment interruption, regardless of...
News
CLL patients ‘cured’: 10 years post infusion, CAR T cells persist
A decade after CAR T’cell treatment, chronic leukemia patients reported “cured,” with cells still detectable.
News
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'
MSKCC medical oncologists share expertise in HSCT, Spanish background, a gift for mentoring, and 100 peer-reviewed publications written together...
